In addition, its expression levels correlated with inflammatory parameters at baseline and in subsequent studies, and treatment significantly decreased IL-38 expression, suggesting that IL-38 might be a potential biomarker for RA (sensitivity = 0.723, specificity = 0.906, and AUC = 0.840) (76). Here, IL1F10 is linked to rheumatoid arthritis.